These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16193090)

  • 1. Translocation t(14;18) and gain of chromosome 18/BCL2: effects on BCL2 expression and apoptosis in B-cell non-Hodgkin's lymphomas.
    Galteland E; Sivertsen EA; Svendsrud DH; Smedshammer L; Kresse SH; Meza-Zepeda LA; Myklebost O; Suo Z; Mu D; Deangelis PM; Stokke T
    Leukemia; 2005 Dec; 19(12):2313-23. PubMed ID: 16193090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma.
    Dierlamm J; Murga Penas EM; Bentink S; Wessendorf S; Berger H; Hummel M; Klapper W; Lenze D; Rosenwald A; Haralambieva E; Ott G; Cogliatti SB; Möller P; Schwaenen C; Stein H; Löffler M; Spang R; Trümper L; Siebert R;
    Haematologica; 2008 May; 93(5):688-96. PubMed ID: 18367485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus.
    Dyer MJ; Lillington DM; Bastard C; Tilly H; Lens D; Heward JM; Stranks G; Morilla R; Monrad S; Guglielmi P; Kluin-Nelemans JC; Hagemeijer A; Young BD; Catovsky D
    Leukemia; 1996 Jul; 10(7):1198-208. PubMed ID: 8684002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular features of a new human lymphoma cell line carrying both BCL2 and BCL6 gene rearrangements.
    Yonetani N; Akasaka T; Akasaka H; Ohno H; Okuma M; Miura I; Takahashi N; Miyanishi S; Okumura A; Muramatsu M; Fukuhara S
    Oncogene; 1998 Aug; 17(8):971-9. PubMed ID: 9747876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.
    Katzenberger T; Ott G; Klein T; Kalla J; Müller-Hermelink HK; Ott MM
    Am J Pathol; 2004 Aug; 165(2):481-90. PubMed ID: 15277222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic, molecular biological and clinical study of B-cell lymphomas with 14;18 translocation in Japanese patients.
    Takechi M; Tanaka K; Hashimoto T; Asaoku H; Dohy H; Kikuchi M; Kamada N
    Leukemia; 1991 Dec; 5(12):1069-75. PubMed ID: 1774956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell non-Hodgkin's lymphoma cell line (Karpas 1106) with complex translocation involving 18q21.3 but lacking BCL2 rearrangement and expression.
    Nacheva E; Dyer MJ; Metivier C; Jadayel D; Stranks G; Morilla R; Heward JM; Holloway T; O'Connor S; Bevan PC
    Blood; 1994 Nov; 84(10):3422-8. PubMed ID: 7949096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene amplification of Japanese non-Hodgkin lymphoma with involvement of the BCL2 gene.
    Miyamura K; Kobayashi T; Sasaki T; Ibuka T; Imai K; Sakai Y; Kawaguchi K; Miyashita T; Iwaya M; Mizutani S
    Int J Hematol; 1991 Apr; 54(2):137-40. PubMed ID: 1747446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody.
    Masir N; Campbell LJ; Jones M; Mason DY
    Pathology; 2010 Apr; 42(3):212-6. PubMed ID: 20350212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid detection of lymphoma-specific translocations in interphase nuclei of non-Hodgkin's lymphoma by fluorescence in situ hybridization.
    Taniwaki M; Ueda Y; Nishida K; Takashima T; Kashima K; Matsuda F; Silverman GA
    Leukemia; 1997 Apr; 11 Suppl 3():291-3. PubMed ID: 9209369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An additional segment at 1p36 derived from der(18)t(14;18) in patients with diffuse large B-cell lymphomas transformed from follicular lymphoma.
    Nomura K; Kanda-Akano Y; Shimizu D; Okuda T; Yoshida N; Matsumoto Y; Nishida K; Taki T; Yokota S; Horiike S; Taniwaki M
    Ann Hematol; 2005 Jul; 84(7):474-6. PubMed ID: 15700138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of BACH2 associated with lower levels of BCL2 transcript abundance in t(14;18)(q21;q34) translocation positive non-Hodgkin's lymphoma.
    Green M; Gandhi MK; Camilleri E; Marlton P; Lea R; Griffiths L
    Leuk Res; 2009 May; 33(5):731-4. PubMed ID: 18929412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of BCL2 and MYC expression in non-Hodgkin's lymphomas by in situ hybridization: correlation with chromosome translocations.
    Murty VV; Ladanyi M; Houldsworth J; Mikraki V; Chaganti RS
    Diagn Mol Pathol; 1992 Dec; 1(4):221-8. PubMed ID: 1342969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
    Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
    J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
    Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
    Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U-2973, a novel B-cell line established from a patient with a mature B-cell leukemia displaying concurrent t(14;18) and MYC translocation to a non-IG gene partner.
    Boström H; Leuchowius KJ; Hallböök H; Nordgren A; Thörn I; Thorselius M; Rosenquist R; Söderberg O; Sundström C
    Eur J Haematol; 2008 Sep; 81(3):218-25. PubMed ID: 18510704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome.
    Barrans SL; Evans PA; O'Connor SJ; Kendall SJ; Owen RG; Haynes AP; Morgan GJ; Jack AS
    Clin Cancer Res; 2003 Jun; 9(6):2133-9. PubMed ID: 12796378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma.
    Stokke T; DeAngelis P; Smedshammer L; Galteland E; Steen HB; Smeland EB; Delabie J; Holte H
    Br J Cancer; 2001 Dec; 85(12):1900-13. PubMed ID: 11747333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type.
    Ott G; Katzenberger T; Greiner A; Kalla J; Rosenwald A; Heinrich U; Ott MM; Müller-Hermelink HK
    Cancer Res; 1997 Sep; 57(18):3944-8. PubMed ID: 9307277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
    Iqbal J; Neppalli VT; Wright G; Dave BJ; Horsman DE; Rosenwald A; Lynch J; Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Campo E; Ott G; Müller-Hermelink HK; Delabie J; Jaffe ES; Grogan TM; Connors JM; Vose JM; Armitage JO; Staudt LM; Chan WC
    J Clin Oncol; 2006 Feb; 24(6):961-8. PubMed ID: 16418494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.